Distribution of baseline EDSS at the time of MS relapse (a) and improvement in EDSS after treatment with intravenous methylprednisolone (b).

<p>Distribution of baseline EDSS at the time of MS relapse (a) and improvement in EDSS after treatment with intravenous methylprednisolone (b).</p>